{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:51:13Z","timestamp":1789771873720,"version":"4.0.1"},"reference-count":96,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"am","delay-in-days":179,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006418","name":"Brown University","doi-asserted-by":"publisher","award":["R25AI140490"],"award-info":[{"award-number":["R25AI140490"]}],"id":[{"id":"10.13039\/100006418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01 CA287008"],"award-info":[{"award-number":["U01 CA287008"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.trre.2024.100860","type":"journal-article","created":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T12:10:47Z","timestamp":1716639047000},"page":"100860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cytomegalovirus infection and cardiovascular outcomes in abdominal organ transplant recipients: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"38","author":[{"given":"Panos","family":"Arvanitis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel R.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Farmakiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2024.100860_bb0005","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00007890-200007270-00013","article-title":"Increased incidence of cardiac complications in kidney transplant recipients with cytomegalovirus disease","volume":"70","author":"Humar","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100860_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ajt.12129","article-title":"Foreword: guidelines 3","volume":"13","author":"Blumberg","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100860_bb0015","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/cid\/ciad643","article-title":"Association of Cytomegalovirus (CMV) DNAemia with long-term mortality in a randomized trial of preemptive therapy and antiviral prophylaxis for prevention of CMV disease in high-risk donor seropositive, recipient seronegative liver transplant recipients","volume":"78","author":"Kumar","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.trre.2024.100860_bb0020","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3947\/ic.2013.45.3.260","article-title":"Cytomegalovirus infections in solid organ transplantation: a review","volume":"45","author":"Ramanan","year":"2013","journal-title":"Infect Chemother"},{"key":"10.1016\/j.trre.2024.100860_bb0025","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.trre.2014.01.001","article-title":"The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients","volume":"28","author":"Roman","year":"2014","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.trre.2024.100860_bb0030","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0140-6736(87)90888-9","article-title":"High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis","volume":"2","author":"Adam","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2024.100860_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11133832","article-title":"The role of CMV infection in primary lesions, development and clinical expression of atherosclerosis","volume":"11","author":"Cristescu","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.trre.2024.100860_bb0040","first-page":"30","article-title":"Cytomegalovirus and atherosclerosis","volume":"14","author":"Melnick","year":"1993","journal-title":"Eur Heart J"},{"key":"10.1016\/j.trre.2024.100860_bb0045","doi-asserted-by":"crossref","first-page":"240","DOI":"10.20411\/pai.v5i1.382","article-title":"Novel strategies to combat CMV-related cardiovascular disease","volume":"5","author":"Vasilieva","year":"2020","journal-title":"Pathog Immun"},{"key":"10.1016\/j.trre.2024.100860_bb0050","first-page":"51","article-title":"Does cytomegalovirus play a role in atherosclerosis?","volume":"7","author":"Bruggeman","year":"2000","journal-title":"Herpes"},{"key":"10.1016\/j.trre.2024.100860_bb0055","article-title":"CMV seroprevalence and coronary CMV-DNA detection in immunocompetent patients with heart diseases","author":"Cento","year":"2022","journal-title":"Minerva Med"},{"key":"10.1016\/j.trre.2024.100860_bb0060","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1469-0691.2002.00407.x","article-title":"Has cytomegalovirus infection any role in the development of atherosclerosis?","volume":"8","author":"Degre","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.trre.2024.100860_bb0065","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz113","article-title":"Association of cytomegalovirus DNA and immunologic markers of cardiovascular disease","volume":"6","author":"Garg","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.trre.2024.100860_bb0070","doi-asserted-by":"crossref","first-page":"42","DOI":"10.14797\/mdcj-8-2-42","article-title":"Cytomegalovirus localization in atherosclerotic plaques is associated with acute coronary syndromes: report of 105 patients","volume":"8","author":"Izadi","year":"2012","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"10.1016\/j.trre.2024.100860_bb0075","first-page":"251","article-title":"Cytomegalovirus-associated thrombosis","volume":"76","author":"Neppelenbroek","year":"2018","journal-title":"Neth J Med"},{"key":"10.1016\/j.trre.2024.100860_bb0080","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/01.RES.75.2.214","article-title":"Active cytomegalovirus infection of arterial smooth muscle cells in immunocompromised rats. A clue to herpesvirus-associated atherogenesis?","volume":"75","author":"Persoons","year":"1994","journal-title":"Circ Res"},{"key":"10.1016\/j.trre.2024.100860_bb0085","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1161\/01.CIR.100.14.1569","article-title":"Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall","volume":"100","author":"Zhou","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.trre.2024.100860_bb0090","doi-asserted-by":"crossref","first-page":"289","DOI":"10.23736\/S0026-4806.22.07778-3","article-title":"CMV seroprevalence and coronary CMV-DNA detection in immunocompetent patients with heart diseases","volume":"114","author":"Cento","year":"2023","journal-title":"Minerva Med"},{"key":"10.1016\/j.trre.2024.100860_bb0095","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/cid\/cit083","article-title":"Seropositivity and higher immunoglobulin g antibody levels against cytomegalovirus are associated with mortality in the population-based European prospective investigation of Cancer-Norfolk cohort","volume":"56","author":"Gkrania-Klotsas","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.trre.2024.100860_bb0100","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1007\/s11033-012-1482-6","article-title":"Cytomegalovirus infection and coronary heart disease risk: a meta-analysis","volume":"39","author":"Ji","year":"2012","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.trre.2024.100860_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104732","article-title":"The direct and indirect consequences of cytomegalovirus infection and potential benefits of vaccination","volume":"176","author":"Griffiths","year":"2020","journal-title":"Antivir Res"},{"key":"10.1016\/j.trre.2024.100860_bb0110","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2174\/187152611797636640","article-title":"Antiviral treatment of cytomegalovirus infection","volume":"11","author":"Ahmed","year":"2011","journal-title":"Infect Disord Drug Targets"},{"key":"10.1016\/j.trre.2024.100860_bb0115","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.antiviral.2006.05.002","article-title":"Antiviral drugs for cytomegalovirus diseases","volume":"71","author":"Biron","year":"2006","journal-title":"Antivir Res"},{"key":"10.1016\/j.trre.2024.100860_bb0120","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.healun.2015.03.015","article-title":"Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation","volume":"34","author":"Delgado","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2024.100860_bb0125","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1399-0012.1996.tb00734.x","article-title":"Cytomegalovirus infection associated accelerated heart allograft arteriosclerosis may impair the late function of the graft","volume":"10","author":"Koskinen","year":"1996","journal-title":"Clin Transpl"},{"key":"10.1016\/j.trre.2024.100860_bb0130","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1034\/j.1399-3062.1999.010205.x","article-title":"Cytomegalovirus infection and cardiac allograft vasculopathy","volume":"1","author":"Koskinen","year":"1999","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.trre.2024.100860_bb0135","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1034\/j.1399-3062.2001.00009.x","article-title":"Role of cytomegalovirus in cardiac allograft vasculopathy","volume":"3","author":"Weill","year":"2001","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.trre.2024.100860_bb0140","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/j.transproceed.2009.07.068","article-title":"Cytomegalovirus infection does not accelerate microvasculopathy development in heart transplant recipients","volume":"41","author":"Zakliczynski","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2024.100860_bb0145","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00001573-199803000-00009","article-title":"Prevention and treatment of cytomegalovirus infection and disease in heart transplant recipients","volume":"13","author":"Avery","year":"1998","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.trre.2024.100860_bb0150","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/S0041-1345(98)00583-1","article-title":"Combined human cytomegalovirus and hepatitis C virus infections increase the risk of allograft vascular disease in heart transplant recipients","volume":"30","author":"Dal Bello","year":"1998","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2024.100860_bb0155","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1097\/01.TP.0000090163.48433.48","article-title":"Cytomegalovirus infection status predicts progression of heart-transplant vasculopathy","volume":"76","author":"Fateh-Moghadam","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100860_bb0160","first-page":"155","article-title":"Cytomegalovirus and coronary artery disease in heart transplant patients--accelerated low density lipoprotein and lipoprotein(a) modification as a proposed factor","volume":"12","author":"Fay","year":"1993","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2024.100860_bb0165","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/tri.13155","article-title":"Diminished impact of cytomegalovirus infection on graft vasculopathy development in the antiviral prophylaxis era - a retrospective study","volume":"31","author":"Goekler","year":"2018","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2024.100860_bb0170","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1111\/j.1600-6143.2009.02801.x","article-title":"Viral infection induces de novo lesions of coronary allograft vasculopathy through a natural killer cell-dependent pathway","volume":"9","author":"Graham","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100860_bb0175","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1001\/jama.1989.03420240075030","article-title":"Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis","volume":"261","author":"Grattan","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.trre.2024.100860_bb0180","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/TP.0000000000001094","article-title":"Cytomegalovirus immunoglobulin after thoracic transplantation: An overview","volume":"100","author":"Grossi","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100860_bb0185","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/TP.0000000000003961","article-title":"Cytomegalovirus donor seropositivity negatively affects survival after heart transplantation","volume":"106","author":"Heim","year":"2022","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100860_bb0190","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1186\/s12879-015-1321-1","article-title":"Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients","volume":"15","author":"Johansson","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.trre.2024.100860_bb0195","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1097\/TP.0000000000003015","article-title":"The association between cytomegalovirus infection and cardiac allograft vasculopathy in the era of antiviral Valganciclovir prophylaxis","volume":"104","author":"Klimczak-Tomaniak","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100860_bb0200","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1600-6143.2005.00785.x","article-title":"Effect of cytomegalovirus on cardiac allograft arteriosclerosis--indirect or direct?","volume":"5","author":"Lemstrom","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100860_bb0205","first-page":"707","article-title":"Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart","volume":"9","author":"Loebe","year":"1990","journal-title":"J Heart Transplant"},{"key":"10.1016\/j.trre.2024.100860_bb0210","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13015","article-title":"Impact of donor and recipient cytomegalovirus serology on long-term survival of heart transplant recipients","volume":"21","author":"Mabilangan","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.trre.2024.100860_bb0215","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13479","article-title":"Impact of late-onset cytomegalovirus infection in the development of cardiac allograft vasculopathy in heart transplant recipients","volume":"23","author":"Ponz de Antonio","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.trre.2024.100860_bb0220","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/01.tp.0000229039.87735.76","article-title":"Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection","volume":"82","author":"Potena","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100860_bb0225","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1111\/tri.1992.5.s1.238","article-title":"Determinants of graft arteriosclerosis after heart transplantation","volume":"5","author":"Scott","year":"1992","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2024.100860_bb0230","doi-asserted-by":"crossref","first-page":"E455","DOI":"10.1111\/j.1399-0012.2011.01459.x","article-title":"The impact of CMV prevention on long-term recipient and graft survival in heart transplant recipients: analysis of the scientific registry of transplant recipients (SRTR) database","volume":"25","author":"Snydman","year":"2011","journal-title":"Clin Transpl"},{"key":"10.1016\/j.trre.2024.100860_bb0235","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1600-6143.2007.02062.x","article-title":"The role of angiogenic and wound repair factors during CMV-accelerated transplant vascular sclerosis in rat cardiac transplants","volume":"8","author":"Streblow","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100860_bb0240","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/jocs.14588","article-title":"Impact of cytomegalovirus serologic status on heart transplantation","volume":"35","author":"Suarez-Pierre","year":"2020","journal-title":"J Card Surg"},{"key":"10.1016\/j.trre.2024.100860_bb0245","first-page":"25","article-title":"Role of CMV in transplant coronary artery disease and survival after heart transplantation","volume":"1","author":"Valantine","year":"1999","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.trre.2024.100860_bb0250","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1600-6143.2003.00316.x","article-title":"The role of viruses in cardiac allograft vasculopathy","volume":"4","author":"Valantine","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100860_bb0255","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.athplu.2022.03.003","article-title":"Role of cytomegalovirus infection after kidney transplantation on the subsequent risk of atherosclerotic and thrombotic events","volume":"48","author":"Rodriguez-Goncer","year":"2022","journal-title":"Atheroscler Plus"},{"key":"10.1016\/j.trre.2024.100860_bb0260","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.trre.2024.100860_bb0265","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jmv.1890440316","article-title":"Investigation of cytomegalovirus infection as a risk factor for coronary atherosclerosis in the explanted hearts of patients undergoing heart transplantation","volume":"44","author":"Dummer","year":"1994","journal-title":"J Med Virol"},{"key":"10.1016\/j.trre.2024.100860_bb0270","article-title":"Cytomegalovirus infection is associated with impaired myocardial flow reserve after heart transplantation","author":"Gondi","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2024.100860_bb0275","first-page":"674","article-title":"Acute vascular rejection of the coronary arteries in human heart transplantation: pathology and correlations with immunosuppression and cytomegalovirus infection","volume":"10","author":"Normann","year":"1991","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2024.100860_bb0280","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-6143.2010.03365.x","article-title":"Cytomegalovirus latency promotes cardiac lymphoid neogenesis and accelerated allograft rejection in CMV naive recipients","volume":"11","author":"Orloff","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100860_bb0285","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.0000138393.99310.1c","article-title":"Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function","volume":"110","author":"Petrakopoulou","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.trre.2024.100860_bb0290","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/TP.0000000000001096","article-title":"Cytomegalovirus hyper immunoglobulin for CMV prophylaxis in thoracic transplantation","volume":"100","author":"Rea","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100860_bb0295","doi-asserted-by":"crossref","first-page":"682","DOI":"10.12659\/AOT.905267","article-title":"Heart transplantation and risk of cardiac vasculopathy development: what factors are important?","volume":"22","author":"Sobieszczanska-Malek","year":"2017","journal-title":"Ann Transplant"},{"key":"10.1016\/j.trre.2024.100860_bb0300","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"10.1016\/j.trre.2024.100860_bb0305","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.trre.2024.100860_bb0310","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.trre.2024.100860_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050951","article-title":"HLA-E-restricted cross-recognition of allogeneic endothelial cells by CMV-associated CD8 T cells: a potential risk factor following transplantation","volume":"7","author":"Allard","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.trre.2024.100860_bb0320","first-page":"49","article-title":"Emerging relations between infectious diseases and coronary artery disease and atherosclerosis","volume":"163","author":"Fong","year":"2000","journal-title":"CMAJ"},{"key":"10.1016\/j.trre.2024.100860_bb0325","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1016\/j.transproceed.2005.08.058","article-title":"Cytomegalovirus replication and \u201cherpesvirus burden\u201d as risk factor of cardiovascular events in the first year after renal transplantation","volume":"37","author":"Gomez","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2024.100860_bb0330","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.904705","article-title":"CMV-responsive CD4 T cells have a stable cytotoxic phenotype over the first year post-transplant in patients without evidence of CMV viremia","volume":"13","author":"Higdon","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.trre.2024.100860_bb0335","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1432-2277.2005.00139.x","article-title":"Cytomegalovirus-enhanced development of transplant arteriosclerosis in the rat; effect of timing of infection and recipient responsiveness","volume":"18","author":"Hillebrands","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2024.100860_bb0340","doi-asserted-by":"crossref","first-page":"S469","DOI":"10.1016\/S0002-8703(99)70277-2","article-title":"Coronary artery disease after heart transplantation and its relation to cytomegalovirus","volume":"138","author":"Hosenpud","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.trre.2024.100860_bb0345","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1086\/527397","article-title":"Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences","volume":"46","author":"Legendre","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.trre.2024.100860_bb0350","first-page":"3552","article-title":"Initial endothelial injury and cytomegalovirus infection accelerate the development of allograft arteriosclerosis","volume":"27","author":"Li","year":"1995","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2024.100860_bb0355","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.transproceed.2006.08.091","article-title":"How to decrease cardiovascular mortality in renal transplant recipients","volume":"38","author":"Ostovan","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2024.100860_bb0360","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/qjmed\/91.3.185","article-title":"CMV infection is associated with transplant renal artery stenosis","volume":"91","author":"Pouria","year":"1998","journal-title":"QJM"},{"key":"10.1016\/j.trre.2024.100860_bb0365","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/jmv.24602","article-title":"Cytomegalovirus antibody and vascular pathology in renal transplant recipients","volume":"89","author":"Price","year":"2017","journal-title":"J Med Virol"},{"key":"10.1016\/j.trre.2024.100860_bb0370","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/modpathol.3880032","article-title":"CMV and transplant-related coronary atherosclerosis: an immunohistochemical, in situ hybridization, and polymerase chain reaction in situ study","volume":"13","author":"Sambiase","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/j.trre.2024.100860_bb0375","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/infdis\/jit065","article-title":"The contribution of cytomegalovirus to atherosclerotic events after kidney transplantation","volume":"207","author":"Shimamura","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.trre.2024.100860_bb0380","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/tri.13160","article-title":"Cardiovascular disease after transplantation: an emerging role of the immune system","volume":"31","author":"Van Laecke","year":"2018","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2024.100860_bb0385","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.4049\/jimmunol.160.7.3143","article-title":"An in vitro model of T cell activation by autologous cytomegalovirus (CMV)-infected human adult endothelial cells: contribution of CMV-enhanced endothelial ICAM-1","volume":"160","author":"Waldman","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.trre.2024.100860_bb0390","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jmv.1890280405","article-title":"Enhanced endothelial cytopathogenicity induced by a cytomegalovirus strain propagated in endothelial cells","volume":"28","author":"Waldman","year":"1989","journal-title":"J Med Virol"},{"key":"10.1016\/j.trre.2024.100860_bb0395","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/vim.2000.13.37","article-title":"Alloreactive cytotoxic CD4+ responses elicited by cytomegalovirus-infected endothelial cells: role of MHC class I antigens","volume":"13","author":"Weinberg","year":"2000","journal-title":"Viral Immunol"},{"key":"10.1016\/j.trre.2024.100860_bb0400","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/infdis\/jit064","article-title":"Cytomegalovirus exposure and cardiovascular disease in kidney transplant recipients","volume":"207","author":"Courivaud","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.trre.2024.100860_bb0405","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/tri.13145","article-title":"Cytomegalovirus reactivation in liver transplant recipients due to hepatitis C cirrhosis is associated with higher cardiovascular risk - an observational, retrospective study","volume":"31","author":"Aguilera","year":"2018","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2024.100860_bb0410","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/cid\/ciaa125","article-title":"Donor graft cytomegalovirus Serostatus and the risk of arterial and venous thrombotic events in seronegative recipients after non-thoracic solid organ transplantation","volume":"72","author":"Belga","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.trre.2024.100860_bb0415","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/15269248211002792","article-title":"Cytomegalovirus disease, short-term cardiovascular events and graft survival in a cohort of kidney transplant recipients with high CMV IgG Seroprevalence","volume":"31","author":"Diaz","year":"2021","journal-title":"Prog Transplant"},{"key":"10.1016\/j.trre.2024.100860_bb0420","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/00007890-200110270-00011","article-title":"Cytomegalovirus disease is not a major risk factor for ischemic heart disease after renal transplantation","volume":"72","author":"Hernandez","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2024.100860_bb0425","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1034\/j.1600-6143.2003.30114.x","article-title":"Determinants of cardiovascular mortality after renal transplantation: a role for cytomegalovirus?","volume":"3","author":"Kalil","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2024.100860_bb0430","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.transproceed.2018.03.126","article-title":"Cytomegalovirus status of kidney transplant recipients and cardiovascular risk","volume":"50","author":"Komorowska-Jagielska","year":"2018","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2024.100860_bb0435","first-page":"1188","article-title":"Association of cytomegalovirus diseases with newly developed myocardial infarction and congestive heart failure: data from a national population-based cohort","volume":"18","author":"Lee","year":"2022","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.trre.2024.100860_bb0440","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.transproceed.2007.02.026","article-title":"The association between cytomegalovirus infection and atherosclerotic events in renal transplant recipients","volume":"39","author":"Ozdemir","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2024.100860_bb0445","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jcv.2012.12.010","article-title":"Limited impact of cytomegalovirus infection in the long-term outcome of renal and liver transplant","volume":"56","author":"San-Juan","year":"2013","journal-title":"J Clin Virol"},{"key":"10.1016\/j.trre.2024.100860_bb0450","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13977","article-title":"Cytomegalovirus in the transplant setting: where are we now and what happens next? A report from the international CMV symposium 2021","volume":"24","author":"Kotton","year":"2022","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.trre.2024.100860_bb0455","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/idr16010005","article-title":"Management of Cytomegalovirus Infections in the era of the novel antiviral players, Letermovir and Maribavir","volume":"16","author":"Piret","year":"2024","journal-title":"Infect Dis Rep"},{"key":"10.1016\/j.trre.2024.100860_bb0460","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1001\/jama.2020.3138","article-title":"Effect of preemptive therapy vs antiviral prophylaxis on cytomegalovirus disease in seronegative liver transplant recipients with seropositive donors: a randomized clinical trial","volume":"323","author":"Singh","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.trre.2024.100860_bb0465","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12879-020-4787-4","article-title":"Clinical experience with a novel assay measuring cytomegalovirus (CMV)-specific CD4+ and CD8+ T-cell immunity by flow cytometry and intracellular cytokine staining to predict clinically significant CMV events","volume":"20","author":"Rogers","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.trre.2024.100860_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2023.116139","article-title":"Using a commercially available assay that measures cytomegalovirus (CMV)-specific T-cell immunity to predict protection against CMV: a prospective, blinded clinical study","volume":"108","author":"Almaghlouth","year":"2024","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.trre.2024.100860_bb0475","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jcv.2019.04.007","article-title":"New vaccines and antiviral drugs for cytomegalovirus","volume":"116","author":"Griffiths","year":"2019","journal-title":"J Clin Virol"},{"key":"10.1016\/j.trre.2024.100860_bb0480","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11908-019-0699-0","article-title":"CMV prevention and treatment in transplantation: What\u2019s new in 2019","volume":"21","author":"Stern","year":"2019","journal-title":"Curr Infect Dis Rep"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X24000430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X24000430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T22:59:28Z","timestamp":1737586768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X24000430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":96,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0955470X24000430"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2024.100860","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytomegalovirus infection and cardiovascular outcomes in abdominal organ transplant recipients: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2024.100860","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100860"}}